Topics

aMoon invests in $80m Adicet Bio financing round

05:15 EDT 3 Oct 2019 | Globes

Based on technology developed by the Technion's Prof. Yoram Reiter, Adicet Bio is developing allogeneic cell therapies for cancer using innovative gamma delta T cells.

Original Article: aMoon invests in $80m Adicet Bio financing round

NEXT ARTICLE

More From BioPortfolio on "aMoon invests in $80m Adicet Bio financing round"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...